Home › Amyotrophic Lateral Sclerosis › California › Los Angeles
Amyotrophic Lateral Sclerosis clinical trials in Los Angeles, CA
5 studies for Amyotrophic Lateral Sclerosis are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
ASSESS ALL ALS Study
RecruitingObservational studyHealthy volunteers welcome
- University of California, Los Angeles, Los Angeles
Study of COYA 302 for the Treatment of ALS
RecruitingPhase 2/3
- Cedars-Sinai Medical Center, Los Angeles
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
RecruitingObservational studyHealthy volunteers welcome
- University of California, Los Angeles, Los Angeles
ALS/MND Natural History Study Data Repository
RecruitingObservational study
- Kaiser Permanente, Los Angeles
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
RecruitingPhase 3
- University of Southern California, Los Angeles
About Amyotrophic Lateral Sclerosis
ALS stands for Amyotrophic Lateral Sclerosis, also called Lou Gehrig's disease. ALS affects the nervous system, causing muscle problems. Find out how.
More about Amyotrophic Lateral Sclerosis on MedlinePlus
Amyotrophic Lateral Sclerosis trials in other cities
- Boston, MA19 studies
- Philadelphia, PA14 studies
- Jacksonville, FL13 studies
- Baltimore, MD13 studies
- New York City, NY11 studies
- Chicago, IL10 studies
- San Diego, CA10 studies
- San Francisco, CA10 studies
- St. Louis, MO9 studies
- Dallas, TX8 studies
- Phoenix, AZ8 studies
- Atlanta, GA8 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.